## 3 Results
### UPLC-MS Chemical Composition
\begin{table}
\begin{tabular}{c c c c c c c} \hline \hline
**No.** & **COMPONENT 1** & **Green** & **Poison** & **V1 CBD** & **Banana** & **Grilla CBD** & **Candy BUD** \\ \hline
1 & \(\delta\)-9-cis-tetrahydrocannabinol, (-)- (THC) & 27.4 \(\pm\) 3.04 & 5.0 \(\pm\) 0.67 & 25.4 \(\pm\) 0.92 & 51.9 \(\pm\) 3.10 & 26.7 \(\pm\) 2.38 \\
2 & & monolinolenin & 1.6 \(\pm\) 0.07 & 2.3 \(\pm\) 0.03 & 8.3 \(\pm\) 0.10 & - & 6.7 \(\pm\) 0.59 \\  & 4-[(2S,3R)-7-hydroxy-3-hydroxymethyl]- & & & & & \\
3 & 5-(3-hydroxypropyl)2,3-dihydro-1- & - & - & 7.1 \(\pm\) 0.09 & - & - \\  & benzofuran-2-yl]-2-methoxyphenyl & - & - & & & \\
6-deoxy-\(\alpha\)-L-manopyranoside & & & & & & \\
4 & cannabigerio acid (CBGA) & 0.5 \(\pm\) 0.05 & - & 6.7 \(\pm\) 0.08 & - & 5.3 \(\pm\) 0.24 \\
5 & gristimerin & 1.3 \(\pm\) 0.06 & 2.4 \(\pm\) 0.28 & 6.0 \(\pm\) 0.08 & 0.3 \(\pm\) 0.01 & - \\
6 & cannflavin B & - & 4.5 \(\pm\) 0.06 & 5.5 \(\pm\) 0.07 & 0.2 \(\pm\) 0.03 & 0.8 \(\pm\) 0.03 \\
7 & uscharidin & - & - & 5.0 \(\pm\) 0.06 & - & - \\
8 & wighteone & - & - & 4.4 \(\pm\) 0.05 & 0.7 \(\pm\) 0.04 & - \\
9 & (5Z,8Z,11Z,14Z)-N-(2-furylmethyl)- & & 8.5 \(\pm\) 0.37 & - & 4.3 \(\pm\) 0.05 & - & 1.8 \(\pm\) 0.08 \\
5,8,11,14-icostreatranamide & & & & & & \\
10 & cannabidic acid (CBDA) & 9.7 \(\pm\) 0.43 & 0.7 \(\pm\) 0.08 & 3.9 \(\pm\) 0.05 & 0.4 \(\pm\) 0.03 & 0.2 \(\pm\) 0.03 \\
11 & cryptocaryl E & tr & tr & 3.5 \(\pm\) 0.04 & - & - \\
12 & 3,14-dihydroxyccard-20(22)-enolide & 1.9 \(\pm\) 0.08 & 3.1 \(\pm\) 0.04 & 3.2 \(\pm\) 0.04 & 0.2 \(\pm\) 0.02 & - \\
13 & tetrahydrocnamabivarin (THCV) & - & - & 3.1 \(\pm\) 0.04 & - & - \\
14 & didrovaltrate & 5.9 \(\pm\) 0.26 & - & 2.7 \(\pm\) 0.03 & - & 6.2 \(\pm\) 0.00 \\
15 & cannabidivarin (CBDV) & - & 1.5 \(\pm\) 0.02 & 2.5 \(\pm\) 0.03 & - & 0.1 \(\pm\) 0.00 \\
16 & acuminatin & - & 0.2 \(\pm\) 0.03 & 1.5 \(\pm\) 0.02 & 0.3 \(\pm\) 0.02 & 0.6 \(\pm\) 0.03 \\
17 & clovanenangololol & - & 11.5 \(\pm\) 0.14 & 1.0 \(\pm\) 0.01 & - & 0.7 \(\pm\) 0.03 \\
18 & artocarppin & - & - & 0.8 \(\pm\) 0.01 & - & 0.7 \(\pm\) 0.03 \\
19 & oregonin & - & - & 0.6 \(\pm\) 0.01 & 0.3 \(\pm\) 0.02 & - \\
20 & 11-nor-9-carboxy-tetrahydrocannabinol & - & 0.3 \(\pm\) 0.00 & 0.6 \(\pm\) 0.01 & 0.1 \(\pm\) 0.01 & 0.1 \(\pm\) 0.00 \\
21 & cannabinoid acid (CBNA) & - & - & 0.5 \(\pm\) 0.01 & 9.0 \(\pm\) 0.60 & - \\
22 & 10-gingerol & 1.8 \(\pm\) 0.08 & 1.3 \(\pm\) 0.02 & 0.5 \(\pm\) 0.01 & - & - \\ methyl (1R,2R,3S,3 ar,8 bs)-2,3,3a,8b- & & & & & & \\
23 & tetrahydro-1,6,8b-trihydroxy-8-methoxy-3a-(4-methoxyphenyl)-3-phenyl-1H- & 1.4 \(\pm\) 0.06 & - & 0.4 \(\pm\) 0.01 & - & 0.8 \(\pm\) 0.04 \\  & cyclopenta[b]benzofuran-2-carboxylate & & & & & \\
24 & labirformidin & 5.7 \(\pm\) 0.25 & 9.6 \(\pm\) 0.12 & 0.4 \(\pm\) 0.00 & - & 0.3 \(\pm\) 0.01 \\
25 & dihydroxykavain & tr & 1.2 \(\pm\) 0.02 & 0.3 \(\pm\) 0.00 & 1.1 \(\pm\) 0.07 & 1.0 \(\pm\) 0.05 \\
26 & citrusoside B & 0.2 \(\pm\) 0.02 & 0.5 \(\pm\) 0.01 & 0.3 \(\pm\) 0.00 & - & 2.2 \(\pm\) 0.10 \\
27 & digitogenin & 0.1 \(\pm\) 0.00 & 0.1 \(\pm\) 0.00 & 0.2 \(\pm\) 0.00 & 0.1 \(\pm\) 0.00 & - \\
4-(6-hydroxy-1,2,3,9a-tetrahydro-3 ah- & & & & & \\
28 & spiro[cyclopenta]bchromeen-9,1’- & tr & - & - & 1.3 \(\pm\) 0.09 & - \\  & cyclopenta]-3a-yl)-1,3-benzenediol & & & & & \\
29 & 5-(3-(2,4-dihydroxycphenyl)propyl)-3,4- & 2.3 \(\pm\) 0.10 & 6.5 \(\pm\) 0.08 & - & - & 31.0 \(\pm\) 1.4 \\  & bis(3-methyl-2-butenyl)- & & & & & \\
5-hydroxy-7-[4-hydroxy-2-methoxy-5-(3-methyl)phenyl]-2,2-dimethyl- & & & & & \\
30 & methyl-2-butenyl]-2,2-dimethyl- & & 13.1 \(\pm\) 0.57 & 13.4 \(\pm\) 0.17 & - & 14.8 \(\pm\) 0.99 & 3.2 \(\pm\) 0.016 \\  & 7,8-dihydro-2H,6H-pyrano[3,2- & & & & & \\  & glchrome-6-one & & & & & \\  & (2R,3R,4R,5R)-2-(1R)-5-[(5R,7R)-1,6- & & & & & \\
31 & dioxaspirot[4.5]dec-7-yl]-1- & & 4.7 \(\pm\) 0.21 & 4.2 \(\pm\) 0.05 & - & 0.3 \(\pm\) 0.01 & 3.2 \(\pm\) 0.15 \\  & hydroxypentyl]-5-(hydroxymethyl)-3,4- & & & & & \\
32 & neritaloside & 0.2 \(\pm\) 0.01 & 0.4 \(\pm\) 0.01 & - & - & 3.0 \(\pm\) 0.14 \\
33 & ananolignan J & 0.4 \(\pm\) 0.02 & 14.1 \(\pm\) 0.17 & - & - & 2.8 \(\pm\) 0.13 \\
34 & 3,12,14-trihydroxycard-20(22)-enolide & 0.1 \(\pm\) 0.00 & 0.3 \(\pm\) 0.00 & - & - & 1.0 \(\pm\) 0.05 \\
35 & gitogenin & - & - & - & 0.2 \(\pm\) 0.01 & 0.8 \(\pm\) 0.03 \\ \hline \hline \end{tabular}
\end{table}